Insight Connection International 2000 Ltd. (ICI) specialises in bringing big ideas to life for purpose-driven organisations. The company focus on the medical field in which we specialise in consulting and helping our clients in the regulatory process of their products.
We also use our local distributor alliances to help our clients sell their products within the region.
In addition, we work together with our clients to identify a promising innovative medical technologies that can become a candidate for investment.
ICI serves a diverse range of clients, including corporate owners & executives and financial investors. This vast range of clients and projects, provides us the deep-sector expertise and unique insights into the dynamics of today’s global challenges and helps us to frame the challenges and opportunities to our clients and equip them with the necessary solutions and vision.
ICI works in close collaboration with several large medical manufacturing companies such as Innova Medical Group, a global leader in the manufacturing and distribution of rapid antigen and antibody test kits for COVID-19 disease detection. EasyDiagnosis, Wuhan EasyDiagnosis Biomedicine Co., Ltd. has been focusing on the independent R&D, production, sales and service for in vitro diagnosis with over 100 Mil. COVID-19 tests in 2020 in over 100+ Countries and regions. Zug Medical Equipment, a French manufacturer of vital signs monitors and ventilators; AMBISEA Technology Corp., a large manufacturer and supplier of personal protection materials and medical equipment to hospitals, organisations and governments worldwide; Rare Biotechnology, a Chinese BioMed company, a long-time manufacturer of diagnostics for over 40 infectious diseases; Nanjing Vazyme Medical Technology Co. Ltd., a manufacturer of reagents and Rapid Serology testing for a large number of diseases and others.
Since the start of the COVID-19 pandemic, the company has started supplying their COVID-19 related products throughout the world (Europe, East Europe, Africa, Middle East, Central and South America)
Upon requests from our customers and medical colleagues, the company has developed an algorithm and strategy for better testing the symptomatic and asymptomatic populations for COVID-19 based on rapid serology and molecular tests and is working in implementing this strategy in various countries, including Israel, The Netherland, Honduras, Panama, Costa Rica and African Union Tourism Organization. For the algorithms please click here: asymptomatic; symptomatic patients.
ICI has chosen the best kits in the market based on parameters such as accuracy, number of patients that were validated, certifications, etc. Our pipeline of COVID-19 products include medical grade high-quality products and certified medical equipment, including but not limited to rapid serology and molecular kits, monitors, ventilators, field hospitals, temperature helmets and personal protection equipment.
Following a vast evaluation according to scientific, regulatory and commercial parameters, Israeli scientists have decided that BIOHIT is the optimal rapid serology test available in the market.
* Fast - results in 10 minutes
* No need for Laboratory equipment
* Simultaneously evaluate IgG and IgM
* FDA approved, CE Mark
* High sensitivity (96.7-100%) and
specificity (96-100%) values
* Accurate sensitivity already on day 8 of
infection (83% for IgM)!
Easy lateral flow device to rapidly detect antigen in serum samples.
* Fast - results in 15 minutes with the use of UV flashlight
* No need for laboratory equipment
* Virus Detection Limit: 20 TCID50/ml
* High sensitivity: 0-3 days following infection (93%); 4-7 days (100%); ≤7 days (96.7%)
* High specificity: 98.9%
Accurate detection of SARS-CoC-2 antigen in serum samples.
* Easy to use
* Virus Detection Limit: 2 TCID50/ml
* Clinical validations on over 700 samples
* High sensitivity: 1-3 days following infection (93.4%); 4-7 days (100%); 8-14 days (90.3%)
* High specificity: 100%
This unique and accurate kit was designed as a fast (results in 5-20 minutes) real time qPCR for COVID-19 detection from RNA samples.
This unique kit has many advantages over other RT-QPCR methods:
*No need for reverse transcription step. *RNA sample one step direct amplification
Amplification time: 5 - 20 minutes only (compared to 1.5 - 2 hours)
*Compatible with any QPCR machine – portable or workstation
*Configuration requirement of instruments: only need 1 optical channel.
The transportable lung ventilator is designed to be used in ambulances, aircrafts, mobile hospitals, emergency services at the hospitals, ship hospitals and during ground transportation.
ICI Offers a wide range of PPE
Chief Financial Officer
Operations and Marketing Manager